Kadrnka F
Eur J Rheumatol Inflamm. 1981;4(2):237-43.
Thirty two patients suffering from radiation or interstitial cystitis were treated according to a method, first described by Marberger, Innsbruck. This method consists of intramural PeroxinormR (orgotein) injections into the bladder wall. The injections were administered during 4 to 6 weekly intervals and were given 1 to 6 times. The dose of injection was between 4 and 6 mg, mostly 12 mg, the total dose administered was between 8 and 72 mg. For the evaluation of the treatment objective and subjective criteria, such as cystoscopic picture, pain at rest, urgency, pollakisuria, incontinence, as well as bladder capacity and micturition frequency, during day and night, were used. In all patients a definite improvement in the symptoms could be observed. All the parameters and especially the bladder capacity and micturition frequency showed remarkable results. Orgotein treatment tolerability was found to be in 90% of the cases from very good to good.
32名患有放射性膀胱炎或间质性膀胱炎的患者按照因斯布鲁克的马尔贝格首次描述的一种方法进行治疗。该方法包括向膀胱壁内注射过氧化酶(奥古蛋白)。注射每隔4至6周进行一次,共注射1至6次。注射剂量在4至6毫克之间,多数为12毫克,总给药剂量在8至72毫克之间。为评估治疗的客观和主观标准,采用了膀胱镜检查图像、静息时疼痛、尿急、尿频、尿失禁以及白天和夜间的膀胱容量和排尿频率等指标。所有患者的症状均有明显改善。所有参数,尤其是膀胱容量和排尿频率,均显示出显著效果。发现90%的病例中奥古蛋白治疗耐受性良好。